Cases | |||
Clinicopathologic factors | Lymph node metastasis (n = 96) | Non-lymph node metastasis (n = 90) | p value |
Gender |
|
| 0.355 |
Male | 74 | 65 |
|
Female | 22 | 25 |
|
Age |
|
| 0.388 |
≤60 | 52 | 56 |
|
>60 | 44 | 34 |
|
Tumor location |
|
| 0.412 |
Upper stomach 1/3 | 25 | 17 |
|
Middle stomach 1/3 | 16 | 17 |
|
Lower stomach 1/3 | 55 | 56 |
|
Gross type |
|
| 0.233 |
Borrmann I | 6 | 8 |
|
Borrmann II | 26 | 32 |
|
Borrmann III | 57 | 41 |
|
Borrmann IV | 7 | 9 |
|
Tumor size |
|
| 0.288 |
≤4 cm | 59 | 63 |
|
>4 cm | 37 | 27 |
|
Tumor depth |
|
| 0.001 |
pT1 | 7 | 34 |
|
pT2 | 21 | 27 |
|
pT3 - 4 | 68 | 29 |
|
Differentiation degree |
|
| 0.155 |
High | 4 | 13 |
|
Medium | 30 | 26 |
|
Low | 62 | 51 |
|
Clinical stage |
|
| 0.0001 |
I | 7 | 45 |
|
II | 17 | 25 |
|
III | 52 | 17 |
|
IV | 20 | 3 |
|
Expression of VEGF-C |
|
| 0.001 |
Positive | 71 | 31 |
|
Negative | 25 | 59 |
|
Expression of VEGFR-3 |
|
| 0.001 |
Positive | 43 | 19 |
|
Negative | 53 | 71 |
|